| Application no. and date | 17740201.3 (espacenet) (Federated) (European Patent Register), 20170630 | | Patent/reg. no. and date | DK/EP 3478843, 20210804 | | Publication date | 20190508 | | Priority no. and date | US 201662357623 P, 20160701, US 201662437592 P, 20161221 | | EP pub. no. and date |
EP 3478843 20190508 | | Effective date | | | Applicant/owner | Somalogic, Inc., 2945 Wilderness Place
Boulder, CO 80301, US | | Applicant ref. no. | V347150DK00 | | Inventor | JANJIC, Nebojsa, 2945 Wilderness Place
Boulder, Colorado 80301, US,
CARTER, Jeff, 2945 Wilderness Place
Boulder, Colorado 80301, US,
SCHNEIDER, Daniel, 2945 Wilderness Place
Boulder, Colorado 80301, US,
GAWANDE, Bharat, 2247 Evening Star Lane
Lafayette, Colorado 80026, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/7115 (2006.01) , C12N 15/11 (2006.01) , C12N 15/115 (2010.01) | | Title | Oligonukleotider omfattende modificerede nukleosider | | Int. application no. | US2017040299 | | Int. publication no. | WO2018005974 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
